CARCELL BIOPHARMA
Carcell Biopharma is a pre-clinical biotech company. Carcell Biopharma develops cell and gene therapy products with an innovative cross-border business model.
CARCELL BIOPHARMA
Social Links:
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2017-01-01
Total Employee:
1+
Status:
Active
Total Funding:
100 M CNY
Current Employees Featured
Founder
Investors List
BioTrack Capital
BioTrack Capital investment in Seed Round - Carcell Biopharma
Hyfinity Investments
Hyfinity Investments investment in Seed Round - Carcell Biopharma
Legend Star
Legend Star investment in Seed Round - Carcell Biopharma
More informations about "Carcell Biopharma"
Carcell Biopharma - Crunchbase Company Profile
Organization. Carcell Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Carcell …See details»
Carcell Biopharma closes an oversubscribed financing round led …
Nov 2, 2021 /CNW/ -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. ... Organization Profile. Carcell Biopharma Inc. Contact …See details»
Carcell Biopharma, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Carcell Biopharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Immune System Diseases, Endocrinology ...See details»
Carcell Biopharma - VentureRadar
Carcell Biopharma specializes in the development of innovative cell and gene therapies. Utilizing their proprietary 'Powertrain' platform, they focus on accelerating the development process …See details»
Portfolio - EVX Ventures
Carcell Biopharma Inc. is an EVX company that develops next generation cell and gene therapies. Based in both Singapore & Shanghai, Carcell is co-founded by industry veterans with work …See details»
Carcell Biopharma | Powertrain Platform: From …
Carcell's Powertrain Platform has two lead technological platforms: (1) Our E3 platform produces exciting red cell therapies to treat autoimmune disorders; (2) We apply high throughput screening philosophies to discover novel and potent …See details»
Carcell welcomes Prof. Harvey Lodish as Chair of its …
Dec 19, 2022 About Carcell Biopharma. Carcell Biopharma is a pre-clinical biotech company launched by EVX Ventures. Operating on a "hub-and-spoke" model, Carcell has two platforms that develops next-generation cell and gene …See details»
Carcell Biopharma - Funding, Financials, Valuation & Investors
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies. New. Resources. Advanced Search. ... How much funding …See details»
Carcell Biopharma | Lipid Nanoparticle (LNP) Licensing …
Licensing only. Carcell has a library of >1000 proprietary ionizable lipids to choose from. These lipids have been tested rigorously in vivo for potency and safety, benchmarking them against some of the lipids found in commercial …See details»
Carcell and CATUG enter into a strategic partnership …
Jan 16, 2024 Carcell Biopharma is a pre-clinical biotech company launched by EVX Ventures. Carcell was founded in 2021 by a team of serial entrepreneurs and seasoned biopharma executives. The co-founders include XQ Lin, the …See details»
Carcell Biopharma | Latest News: From Singapore, Shanghai and …
Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments Advancing the next generation of cell and gene therapies via a "platform of platforms" model …See details»
Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific ...
Dec 20, 2022 SINGAPORE and SHANGHAI, Dec. 19, 2022 -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the Chair of the …See details»
New Jersey Biotech, Pharma & Medical Device Company List
Sterile pharmaceutical company that develops injectable and ophthalmic drugs: Oticon : Somerset, NJ: Hearing Aids: Prinston Pharmaceutical : Somerset, NJ: Generics: Sannova …See details»
Carcell Biopharma closes an oversubscribed financing round led …
Nov 2, 2021 Advancing the next generation of cell and gene therapies via a “platform of platforms” modelSINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", …See details»
Carcell Biopharma - Contacts, Employees, Board Members
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies. ... Experience the new Crunchbase, powered by AI . …See details»
CARC 101C - AdisInsight
15 Aug 2024 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School and Carcell Biopharma plans phase-0 trial for Type 1 diabetes mellitus (In Adults) in China , …See details»
Cure Rare Disease
Cure Rare Disease, a non-profit organization (Tax ID number 82-2473513), is qualified as a tax-exempt organization under section 501(c)(3) of the IRS and has been designated as a “public …See details»
Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare …See details»
CAR-T cell therapy is revolutionising cancer treatment – here’s …
1 day ago Disclosure statement. Lydia Begoña Horndler Gil does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this …See details»
Who We Are - Virginia Breast Cancer Foundation
The Virginia Breast Cancer Foundation (VBCF) was founded in 1991 by five women – Phoebe Antrim, Judi Ellis, Patti Goodall, Mary Jo Kahn, and Sherry Kohlenberg – who met in an MCV …See details»